NO20035572L - Fremgangsmate til fremstilling av piperidinderivatet fexofenadin - Google Patents

Fremgangsmate til fremstilling av piperidinderivatet fexofenadin

Info

Publication number
NO20035572L
NO20035572L NO20035572A NO20035572A NO20035572L NO 20035572 L NO20035572 L NO 20035572L NO 20035572 A NO20035572 A NO 20035572A NO 20035572 A NO20035572 A NO 20035572A NO 20035572 L NO20035572 L NO 20035572L
Authority
NO
Norway
Prior art keywords
fexofenadine
preparing
piperidine derivative
piperidine
derivative
Prior art date
Application number
NO20035572A
Other languages
English (en)
Norwegian (no)
Other versions
NO20035572D0 (no
Inventor
Collin Schroeder
Ryan Huddleston
Richard Charles
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20035572D0 publication Critical patent/NO20035572D0/no
Publication of NO20035572L publication Critical patent/NO20035572L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20035572A 2001-06-15 2003-12-12 Fremgangsmate til fremstilling av piperidinderivatet fexofenadin NO20035572L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29839701P 2001-06-15 2001-06-15
PCT/EP2002/006424 WO2002102776A1 (fr) 2001-06-15 2002-06-12 Procede de production du derive fexofenadine de piperidine

Publications (2)

Publication Number Publication Date
NO20035572D0 NO20035572D0 (no) 2003-12-12
NO20035572L true NO20035572L (no) 2004-02-16

Family

ID=23150325

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035572A NO20035572L (no) 2001-06-15 2003-12-12 Fremgangsmate til fremstilling av piperidinderivatet fexofenadin

Country Status (23)

Country Link
US (2) US6743941B2 (fr)
EP (1) EP1401816B1 (fr)
JP (1) JP4344230B2 (fr)
KR (1) KR100903285B1 (fr)
CN (1) CN1229347C (fr)
AR (1) AR037005A1 (fr)
AT (1) ATE386021T1 (fr)
AU (1) AU2002320847B2 (fr)
BR (1) BR0210410A (fr)
CA (1) CA2450313C (fr)
DE (1) DE60225008T2 (fr)
DK (1) DK1401816T3 (fr)
ES (1) ES2298384T3 (fr)
HK (1) HK1063795A1 (fr)
HU (1) HUP0401125A2 (fr)
IL (2) IL159304A0 (fr)
MX (1) MXPA03010960A (fr)
NO (1) NO20035572L (fr)
NZ (1) NZ530153A (fr)
PL (1) PL364369A1 (fr)
PT (1) PT1401816E (fr)
WO (1) WO2002102776A1 (fr)
ZA (1) ZA200308697B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
CN100453522C (zh) * 2005-01-26 2009-01-21 中国科学技术大学 4-[4-(1-乙氧基酰基-1-甲基乙基苯)]-4-氧代丁酸的制备方法
WO2007135693A2 (fr) * 2006-05-18 2007-11-29 Ind-Swift Laboratories Limited Intermédiaires utiles pour la préparation d'un dérivé de la pipéridine antihistaminique
ITMI20061491A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
CN102070490B (zh) * 2009-11-21 2014-07-30 浙江华海药业股份有限公司 一种非索非那定中间体2-(4-(4-羟基丁酰基)苯基)-2-甲基丙氰的制备方法
CN102070570A (zh) * 2009-11-21 2011-05-25 浙江华海药业股份有限公司 一种非索非那定中间体2-甲基-2(4-(2-氧代四氢呋喃-3-羰基)苯基)丙氰及其盐的制备方法
PL3842429T3 (pl) 2015-06-15 2023-02-20 Asana Biosciences, Llc Heterocykliczne inhibitory ERK1 i ERK2 oraz ich zastosowanie w leczeniu nowotworu złośliwego
CN104876853B (zh) * 2015-06-17 2017-06-16 苏州卫生职业技术学院 盐酸非索非那定的合成方法
DK3365327T3 (da) 2015-10-22 2020-02-24 Sanofi Aventis Deutschland Fremgangsmåde til fremstilling af fexofenadin og mellemprodukter, der anvendes deri
TW202128665A (zh) 2019-10-28 2021-08-01 美商阿沙納生物科學公司 使用ｅｒｋ１與ｅｒｋ２之雜環抑制劑之改良之方法、套組、組成物及給藥攝生法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2946809A1 (de) * 1979-11-20 1981-06-11 A. Nattermann & Cie GmbH, 5000 Köln 4-phenyl-4-oxo-buttersaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende arzneimittel
IT1200123B (it) 1985-09-27 1989-01-05 Ind Chimica Srl Procedimento per la preparazione di alfa-(p-terbutilfenil)-4-(idrossidifenilmetil)-1-piperidinobutanolo
EP0347123A3 (fr) 1988-06-17 1991-07-03 Fisons Corporation Dibenzo-cycloheptényl, -cycloheptyl et oxépinyl amines ayant des propriétés antihistaminiques
IT1249684B (it) 1991-07-19 1995-03-09 Sorin Biomedica Spa Epitopi della proteina env del virus dell'epatite c.
DK0635004T3 (da) * 1992-04-10 2002-11-11 Merrell Pharma Inc 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
HU226559B1 (en) 1993-06-24 2009-03-30 Amr Technology Process for the production of piperidine derivatives

Also Published As

Publication number Publication date
HK1063795A1 (en) 2005-01-14
ATE386021T1 (de) 2008-03-15
HUP0401125A2 (hu) 2004-09-28
NZ530153A (en) 2005-07-29
IL159304A (en) 2010-02-17
CA2450313A1 (fr) 2002-12-27
CN1516689A (zh) 2004-07-28
MXPA03010960A (es) 2004-02-27
PL364369A1 (en) 2004-12-13
BR0210410A (pt) 2004-08-17
WO2002102776A1 (fr) 2002-12-27
CN1229347C (zh) 2005-11-30
DE60225008D1 (de) 2008-03-27
JP4344230B2 (ja) 2009-10-14
KR100903285B1 (ko) 2009-06-17
AU2002320847B2 (en) 2007-09-20
US7235665B2 (en) 2007-06-26
EP1401816A1 (fr) 2004-03-31
JP2005502603A (ja) 2005-01-27
CA2450313C (fr) 2010-08-10
EP1401816B1 (fr) 2008-02-13
US6743941B2 (en) 2004-06-01
KR20040010720A (ko) 2004-01-31
ES2298384T3 (es) 2008-05-16
ZA200308697B (en) 2004-09-03
IL159304A0 (en) 2004-06-01
PT1401816E (pt) 2008-04-08
US20040198983A1 (en) 2004-10-07
NO20035572D0 (no) 2003-12-12
DE60225008T2 (de) 2009-01-29
AR037005A1 (es) 2004-10-20
US20030105329A1 (en) 2003-06-05
DK1401816T3 (da) 2008-06-09

Similar Documents

Publication Publication Date Title
ATE507201T1 (de) Energiegünstiges carbonylierungsverfahren
HK1072251A1 (en) Piperidine derivative
IS5982A (is) Aðferð til framleiðslu á 5-sýanóþalíði
IS8122A (is) Aðferð til að framleiða N-útskipt 2-sýanópýrrólídín
IS6487A (is) Aðferð til framleiðslu á Sítalóprami
IS5715A (is) Aðferð til smíði á 4-karboxýamínó-2-setnu-1,2,3,4-tetrahýdrókínólíni
IS7834A (is) Aðferð til nýmyndunar á bensímídasólefnasambandi
ID28724A (id) Proses untuk memproduksi sikloalkanon
IS7239A (is) Aðferð til framleiðslu á essítalóprami
NO20035572L (no) Fremgangsmate til fremstilling av piperidinderivatet fexofenadin
IS7153A (is) Aðferð til framleiðslu á 14-hýdroxýnormorfínon afleiðu
FI20011889A (fi) Menetelmä ksylitolin valmistamiseksi
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
DK1362040T3 (da) Fremgangsmåde til fremstilling af mesylater af piperidinderivater
ID29787A (id) Proses untuk memproduksi cairan kaya-metana
MXPA03009806A (es) Derivados de piperazino y su uso como inhibidor de fosfodiesterasa de nucleotido ciclico de tipo 4 (pde4).
FI20010987A0 (fi) Uuttoprosessi
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
NO20001134L (no) FremgangsmÕte for fremstilling av VCM
NO20043760L (no) Fremgangsmate til fremstilling av olefiner
ID30126A (id) METODE UNTUK MENGHASILKAN SIKLO-(Asp-DPhe-NMeVal-Arg-Gly)
FI20011563A (fi) Järjestely tuotantolaitosta varten
EE200300204A (et) Meetod distamütsiini derivaadi valmistamiseks
NO20035138D0 (no) Fremgangsmåte til fremstilling av amorft natriumsilastatin
IS5212A (is) Bætt aðferð til framleiðslu á pýrazólópýrimidínónafleiðu